A more effective shingles vaccine is expected to become available in South Africa by the end of June 2026. However, its price and planned private-sector launch could place it beyond the reach of many patients. Shingrix is manufactured by pharmaceutical company GlaxoSmithKline, or GSK. The South African Health Products Regulatory Authority recently registered the vaccine. SAHPRA registration means Shingrix can…
Tag: GSK
-
AI in Drug Development helps Pharma Cut Trial Admin Time
Artificial intelligence is still struggling to crack the most complex problem in pharma R&D: reliably designing new molecules that become breakthrough medicines. But drugmakers say AI is already paying off in the “unsexy” middle of development. This is where time and money are often lost to paperwork, vendor hand-offs, and slow trial start-up. At the JPMorgan Healthcare Conference in January…